Individuals or organizations who wish to comment on Board activities are encouraged to review past Board meeting minutes, submitted public comments, and other relevant documents via the Board website. Notably, the Board is currently receiving presentations regarding the utilization of Medicare MFP (Maximum Fair Price) determinations in determining given drug UPLs (Upper Price Limits), which they are currently receiving feedback on.

Next Meetings

The next PDAB meeting will be on 10/5.